An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
This study conducted to more fully evaluate the way that carbidopa/levodopa and entacapone
may work in the brain. This research study uses [123I]-IBZM and dynamic SPECT imaging to
determine the amount and the duration of dopamine release from specific regions in the brain
after treatment with either the combination of carbidopa/levodopa or the combination of
carbidopa/levodopa/entacapone.